 Home > Medical News > Latest Medical News > The EU's first migraine drug with both curative/preventive action!

The EU's first migraine drug with both curative/preventive action!

 Last Update: 2022-05-16
 Source: Internet
 Author: User

Tags

hyperphosphatemia treatment

kallmann syndrome treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompilationFan Dongdong

Recently, Vydura (rimegepant), a calcitonin gene-related peptide (CGRP) receptor antagonist developed by Pfizer and Biohaven, received marketing authorization from the European Commission (EC) for the treatment of acute migraine with or without aura, and Prevention of adult-onset migraine headaches with at least 4 attacks per month

Globally, migraine affects women three to four times more than men, and in Europe alone about one in 10 people suffer from migraines

Results of a phase 3 study previously published in The Lancet showed that a single dose of rimegepant reduced pain and improved migraine-related symptoms within two hours compared to a placebo

rimegepant is a small molecule oral calcitonin gene-related peptide (CGRP) receptor antagonist, which was launched in the United States in February 2020.

This time, rimegepant was finally approved for marketing in Europe, following the approval recommendation made by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) in February

Reference source: Pfizer and Biohaven's VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.